JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
about
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 17 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@en
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@nl
type
label
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@en
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@nl
prefLabel
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@en
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@nl
P2093
P356
P1476
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@en
P2093
Alan H Shih
Allison N Lau
Amritha Varshini Hanasoge Somasundara
Andrew M Intlekofer
Anna Sophia McKenney
April Chiu
Barbara Spitzer
Craig B Thompson
Efthymia Papalexi
Elizaveta Freinkman
P356
10.1172/JCI124920
P407
P577
2018-09-17T00:00:00Z